Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ULTRA-T2D Study: Uric Acid Lowering Trial in Youth Onset T2D

NCT03899883 is registered in ClinicalTrials.gov with University of Colorado, Denver as lead sponsor.

NCT NCT03899883
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03899883 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ULTRA-T2D Study: Uric Acid Lowering Trial in Youth Onset T2D
Lead sponsor
University of Colorado, Denver
Phase
Phase 2
Overall status
Completed
Start date
January 1, 2020
Completion date
April 13, 2023
Enrollment
11 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes, diabetes complications, diabetes mellitus, type 2, diabetic kidney disease, diabetic nephropathies, hyperuricemia, type 2 diabetes mellitus, type2 diabetes